We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$234M
AUM Growth
-$93.7M
Cap. Flow
-$86.8M
Cap. Flow %
-37.11%
Top 10 Hldgs %
27.68%
Holding
338
New
19
Increased
53
Reduced
178
Closed
87

Top Buys

1
EA icon
Electronic Arts
EA
+$3.29M
2
WST icon
West Pharmaceutical
WST
+$2.66M
3
AVGO icon
Broadcom
AVGO
+$2.25M
4
AXON
Axon Enterprise
AXON
+$2.12M
5
NKE icon
Nike
NKE
+$2.06M

Top Sells

1
PFE icon
Pfizer
PFE
+$4.16M
2
UTHR icon
United Therapeutics
UTHR
+$4.06M
3
RBA icon
RB Global
RBA
+$3.88M
4
TTC icon
Toro Company
TTC
+$3.77M
5
SJM icon
J.M. Smucker
SJM
+$3.5M

Sector Composition

1 Healthcare 25.08%
2 Consumer Staples 21.87%
3 Technology 13.57%
4 Financials 11.99%
5 Communication Services 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAT icon
226
Applied Materials
AMAT
$421B
$3K ﹤0.01%
18
-624
-97% -$105K
ISRG icon
227
Intuitive Surgical
ISRG
$122B
$3K ﹤0.01%
6
-432
-99% -$239K
KLAC icon
228
KLA
KLAC
$278B
$3K ﹤0.01%
50
-1,200
-96% -$86.4K
ROP icon
229
Roper Technologies
ROP
$36.6B
$3K ﹤0.01%
5
-154
-97% -$86.4K
TROW icon
230
T. Rowe Price
TROW
$25.1B
$3K ﹤0.01%
+36
New +$3.8K
ADP icon
231
Automatic Data Processing
ADP
$102B
$2K ﹤0.01%
8
-474
-98% -$143K
DRI icon
232
Darden Restaurants
DRI
$22.7B
$2K ﹤0.01%
+11
New +$2.12K
EQIX icon
233
Equinix
EQIX
$101B
$2K ﹤0.01%
2
-129
-98% -$116K
IRM icon
234
Iron Mountain
IRM
$36.8B
$2K ﹤0.01%
19
-690
-97% -$66.5K
MANH icon
235
Manhattan Associates
MANH
$9.66B
$2K ﹤0.01%
+13
New +$2.71K
PEG icon
236
Public Service Enterprise Group
PEG
$39.2B
$2K ﹤0.01%
+19
New +$1.58K
SNPS icon
237
Synopsys
SNPS
$73.6B
$2K ﹤0.01%
5
-160
-97% -$77.7K
AMGN icon
238
Amgen
AMGN
$198B
$1K ﹤0.01%
3
-710
-100% -$210K
APD icon
239
Air Products & Chemicals
APD
$65.8B
$1K ﹤0.01%
3
-321
-99% -$99K
CG icon
240
Carlyle Group
CG
$16.6B
$1K ﹤0.01%
+24
New +$1.19K
CRWD icon
241
CrowdStrike
CRWD
$207B
$1K ﹤0.01%
12
-1,320
-99% -$126K
CSGP icon
242
CoStar Group
CSGP
$12.2B
$1K ﹤0.01%
+13
New +$989
EME icon
243
Emcor
EME
$33.1B
$1K ﹤0.01%
+4
New +$1.73K
FDS icon
244
Factset
FDS
$9.18B
$1K ﹤0.01%
3
-156
-98% -$71K
FFIV icon
245
F5
FFIV
$23.1B
$1K ﹤0.01%
+4
New +$1.12K
GGG icon
246
Graco
GGG
$12.4B
$1K ﹤0.01%
+16
New +$1.35K
GWW icon
247
W.W. Grainger
GWW
$65.9B
$1K ﹤0.01%
1
-65
-98% -$67.2K
MRSH
248
Marsh
MRSH
$87.8B
$1K ﹤0.01%
6
-689
-99% -$156K
REGN icon
249
Regeneron Pharmaceuticals
REGN
$70.9B
$1K ﹤0.01%
2
-595
-100% -$409K
TXN icon
250
Texas Instruments
TXN
$258B
$1K ﹤0.01%
7
-1,144
-99% -$214K
8 9
10
11 12

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q1 2025 Portfolio in Review

As of Q1 2025, TOBAM held 338 positions worth $234M, down 29% from $328M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TOBAM withdrew a net $86.8M in Q1 2025, closing 87 positions and reducing 178 holdings. Its most notable exit was Toro Company, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Expeditors International worth $1.14M.

  • TOBAM's largest Q1 2025 buy was Expeditors International: 9,454 shares worth $1.14M.
  • TOBAM added most to Electronic Arts in Q1 2025, an estimated $3.29M increase.
  • TOBAM's biggest Q1 2025 reduction was Pfizer, cutting an estimated $4.16M.
  • TOBAM fully exited Toro Company in Q1 2025, selling an estimated $3.77M.
  • TOBAM's ten largest holdings make up 28% of its $234M portfolio in Q1 2025.
  • TOBAM opened 19 new positions and closed 87 in Q1 2025.
  • TOBAM's portfolio value fell 29% quarter-over-quarter to $234M.

Based on TOBAM's 13F filing for Q1 2025, filed 16 Apr 2025.